• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI

2

Despite having a $165 million net worth, Scarlett Johansson says work-life balance doesn’t exist—and the first step to success is admitting that

3

The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises

1

Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI

2

Despite having a $165 million net worth, Scarlett Johansson says work-life balance doesn’t exist—and the first step to success is admitting that

3

The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
CommentaryAdvertising

Weight Watchers CEO: what the GLP-1 Super Bowl ads are missing

By
Tara Comonte
Tara Comonte
Down Arrow Button Icon
By
Tara Comonte
Tara Comonte
Down Arrow Button Icon
February 9, 2026, 9:00 AM ET
tara comonte
Tara Comonte is CEO of Weight Watchers.courtesy of Weight Watchers

Yesterday, millions of Americans tuned in to watch the Super Bowl – and as is tradition, millions more tuned in for the commercials. Alongside the usual ads for beer, snack foods, and food delivery, a new product took center stage: GLP-1 weight loss medication, marketed in several high-profile campaigns that made clear just how mainstream these therapies have become.

Recommended Video

It was, in many ways, a cultural milestone. GLP-1 medications represent one of the most significant advances in weight management in generations, fundamentally reshaping what is possible for people living with overweight or obesity. They help regulate appetite and improve metabolic health, aiding millions in achieving meaningful weight loss. As they become more accessible and accepted, the demand for GLP-1s will only continue to grow. 

But what those ads don’t show—and what much of the broader conversation still overlooks—is what happens next. How do people sustain results over time? And what does a healthy, livable lifestyle look like, both on and off medication?

Weight Watchers has embraced the incredible potential of GLP-1s by building a nationwide team of clinicians who prescribe both the oral and injectable treatments through our Med+ program. But six decades of leadership in this industry has taught us that lasting weight health doesn’t come from a single intervention. It is built over time—through daily choices, consistent support, and the work that goes into sustaining progress long after initial motivation may fade. 

These transformative medications have become a vital part of weight loss journeys for one in eight Americans already, with millions more expected to begin taking them in the months and years ahead. But as the door opens to widespread use of GLP-1s, this next chapter will shift from access to success – from “How do I get GLP-1s?” to “How do I live on them and sustain results over time?”

An Ecosystem of Care 

We know that GLP-1s deliver their most impactful results when they are part of an integrated model of care that combines medication with other healthy habits around diet and exercise, not a prescription-only experience.  

In fact, we have found the difference between medication-only and medication-plus-behavioral- support to be striking.  

In our Med+ program, members prescribed GLP-1 medications lost an average of 21% of their body weight at 12 months, powerful real-world results. But medication isn’t the whole story. In fact, we see members who pair medication with regular engagement in our GLP-1 Success Program losing about 29% more weight over the same timeframe than those who don’t engage. Testament to the powerful combined impact of medication with comprehensive support and tools to achieve even better results.

Weight Watchers works—and the more members engage, the better it works.

GLP-1s have demonstrated a powerful ability to reduce cravings and improve blood sugar, reshaping how we fundamentally understand obesity. Weight gain is not a failure of willpower, it is driven by biology. And that doesn’t change when medication stops, because in the real world, many people don’t expect—or want—to stay on these medications forever. Research published in the British Medical Journal (BMJ) found that while GLP-1s produce substantial initial weight loss, many people regain weight after discontinuing treatment. 

The takeaway is clear: as powerful as these medications are, GLP-1s deliver their greatest impact when they are part of something larger than a prescription-only transactional moment of access. Medication alone cannot teach healthy habits. It can’t teach someone how to nourish their body, prioritize sleep, build strength, or manage stress—all essential components of long-term weight health.

That is why at Weight Watchers we view GLP-1s as transformational tools, but not standalone solutions. Building on our 60-year foundation we have created an integrated model that pairs medication with structured nutritional, behavioral, and lifestyle support, so our members are not only able to successfully meet their weight goals, but be best positioned to maintain them. 

A Promising Future with Integrated Support

This is not a critique of weight loss medications—far from it. 

GLP-1s are reshaping what’s possible in weight management at a time when nearly 75% of American adults live with overweight or obesity. But obesity is a complex, chronic condition—and lasting impact will not come from better drugs alone. It will come from the systems we build to support people over time. 

The path forward may be more complex than 30-second ads suggest, but the future of weight management has never been more promising. When we pair medical innovation with compassion, community, and ongoing support, we move beyond short-term weight loss to lasting health—creating outcomes people can live with not just for a season, but for many Super Bowls to come.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Author
By Tara Comonte
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Tara Comonte has served as President and Chief Executive Officer of Weight Watchers since February 2025 and has been a director since June 2023. She previously served as Interim President and CEO from September 2024 to February 2025. With over two decades of executive leadership experience across corporate and digital strategy, technology, operations and finance, Ms. Comonte has navigated a broad range of industries and complex business transitions.

She served as CEO of TMRW Life Sciences, Inc., a life sciences technology company focused on the in vitro fertilization (IVF) sector, from May 2021 to July 2023, and as a member of its board of directors from December 2018 to September 2023. She previously worked at Shake Shack Inc. as President and CFO from October 2019 to May 2021 and CFO from June 2017. Prior to that, Ms. Comonte was with Getty Images Holdings, Inc., where she served as Chief Financial & Business Affairs Officer and Executive Vice President from October 2016 to June 2017 and CFO and Senior Vice President from April 2013 to October 2016. She previously served as CFO at McCann Worldgroup, the world’s largest marketing communications business, from October 2010 to April 2013. Earlier in her career, she was a founding member and Global CFO & Chief Operating Officer of Mediabrands, part of Interpublic Group, and held various roles at publicly traded companies and Ernst & Young where she qualified as a Chartered Accountant.


Latest in Commentary

liberman
Commentarystart-ups
We watched social media concentrate. The same thing is happening in AI, only at a deeper layer
By David Liberman and Daniil LibermanMay 16, 2026
8 hours ago
olivier
CommentaryAnthropic
I’ve been studying Big Tech for a long time. What just happened with Anthropic and the Pentagon terrifies me
By Olivier SylvainMay 16, 2026
10 hours ago
lawyer
CommentaryLaw
Would you hire the lawyer who just got sanctioned for using AI?
By Alexandra SmythMay 16, 2026
11 hours ago
greg
Personal FinanceAviation
Mamdani’s New York is coming to tax your private jet. Here’s how to prepare
By Greg RaiffMay 16, 2026
12 hours ago
chase
CommentaryCities
San Francisco has $2 trillion in AI wealth and can’t fix its own city. That’s every city’s problem
By Chase GarbarinoMay 15, 2026
1 day ago
lori
Commentarymental health
I run Valvoline Instant Oil Change and work with young people every day. They’re in crisis—and we all have to try to help
By Lori FleesMay 15, 2026
1 day ago

Most Popular

Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI
By Jake AngeloMay 16, 2026
9 hours ago
Despite having a $165 million net worth, Scarlett Johansson says work-life balance doesn’t exist—and the first step to success is admitting that
Success
Despite having a $165 million net worth, Scarlett Johansson says work-life balance doesn’t exist—and the first step to success is admitting that
By Preston ForeMay 13, 2026
3 days ago
The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
Politics
The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promises
By Jake AngeloMay 12, 2026
4 days ago
Current price of oil as of May 15, 2026
Personal Finance
Current price of oil as of May 15, 2026
By Joseph HostetlerMay 15, 2026
1 day ago
Meet the 20-year-old CEO who launched a company in high school to solve Gen Z's entry-level job crisis
Future of Work
Meet the 20-year-old CEO who launched a company in high school to solve Gen Z's entry-level job crisis
By Jake AngeloMay 16, 2026
13 hours ago
‘You’re not a hero, you’re a liability’: Shark Tank’s Kevin O’Leary warns Gen Z founders to stop glorifying hustle culture
Future of Work
‘You’re not a hero, you’re a liability’: Shark Tank’s Kevin O’Leary warns Gen Z founders to stop glorifying hustle culture
By Jacqueline MunisMay 16, 2026
9 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.